However, based on multivariate analysis, CIP4 expression (HR: 0.61, 95% CI: 0.326–0.912, P = 0.012) remained associated with overall survival, along with gender (HR: 0.375 95% CI: 0.179–0.784 P = 0.009), tumor stage (HR: 1.547, 95% CI: 1.497–4.771, P = 0.045) and metastasis (HR: 2.031, 95% CI: 1.059–3.897, P = 0.033). The gene discussed is TRIP10; the disease is neoplasm.